Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The rapid growth of a pleomorphic adenoma of the parotid gland in the third trimester of pregnancy

  • Frederike Palluch1,
  • Martin Lehmann1,
  • Joachim Volz2,
  • Tahwinder Upile3 and
  • Holger Sudhoff1Email author
Journal of Medical Case Reports20115:141

https://doi.org/10.1186/1752-1947-5-141

Received: 4 January 2010

Accepted: 9 April 2011

Published: 9 April 2011

Abstract

Introduction

We report a case highlighting the multidisciplinary management of a giant pleomorphic adenoma of the parotid gland that showed rapid growth in the third trimester of pregnancy.

Case presentation

A 43-year-old Caucasian woman presented in her 32nd week of gestation with a tumor of the parotid gland. Ultrasonography of her neck showed a parotid lesion of 40 × 30 × 27.5 mm. A follow-up magnetic resonance imaging scan of the neck four weeks later revealed that the tumor had grown to 70 × 60 × 60 mm, reaching the parapharyngeal space with marked obstruction of the oropharynx of about 50%. After discussing the case with our multidisciplinary tumor board and the gynecologists it was decided to deliver the baby by caesarean section in the 38th week of gestation, and then to perform a surgical resection of the tumor.

Conclusion

Indications for early surgical intervention of similar cases should be discussed on an individual patient basis in a multidisciplinary setting.

Introduction

With an incidence of 65%, pleomorphic adenoma is the most common tumor of the salivary glands [1], and 80% of the pleomorphic adenomas are located in the parotid gland. These tumors are characterized by slow growth over a period of years, and tend to remain asymptomatic. In 4% of cases, they turn into malignant tumors. In the following case report, we describe a pleomorphic adenoma of the parotid gland that showed rapid growth within the third trimester of pregnancy.

Case presentation

A 43-year-old Caucasian woman presented in her 32nd week of gestation with a tumor of the parotid gland. She had noticed the swelling increasing over the past six months. She was otherwise asymptomatic, without any pain, mouth-opening difficulties or facial nerve dysfunction. Ultrasonography of her neck showed a parotid lesion 40 × 30 × 27.5 mm in size, with an heterogeneous appearance. Considering her advanced state of pregnancy, we advised conservative management in the form of watchful waiting and regular review until the birth.

At our patient's next review, only five weeks later, we noticed rapid growth of the lesion with expansion into the parapharyngeal space. There was still no facial nerve involvement, although our patient's mouth opening was slightly limited. Magnetic resonance imaging (MRI) of the neck showed that the tumor had increased to 70 × 60 × 60 mm, reaching the parapharyngeal space with marked obstruction of the oropharynx of about 50% (Figures 1, 2). Further diagnostic tests such as fine-needle aspiration cytology (FNAC) were discussed. We were concerned about the risk of malignancy and increasing local complications due to the rapid growth. Considering the risk of spreading tumor cells and the unreliability of FNAC in identifying the malignant nature of parotid carcinoma [2], we decided to perform surgical resection to prevent further complications and to obtain a secure diagnosis.
Figure 1

A coronal T2-weighted MRI of the head and neck region (36th week of pregnancy). The left parotid mass is seen distorting the pharynx. The outline of the heterogeneous lesion is clearly demarcated, and tissue planes preserved.

Figure 2

An axial T2-weighted MRI of the head and neck region (36th week of pregnancy). The outline of the heterogeneous left parotid lesion is again clearly demarcated and tissue planes preserved. The oropharyngeal lumen is distorted.

After discussing this case with the gynecologists at our interdisciplinary tumor board meeting, it was decided to deliver the baby by caesarean section in the 38th week of gestation with epidural anesthesia using mepivacain and sufentanil. The surgical resection of the tumor was performed four days later. It was possible to completely remove the tumor via a standard cervicofacial incision without the need to resect the mandible. Although the tumor had stretched the facial nerve to double its usual length, there was no postoperative nerve dysfunction (House Brackmann grade I).

On histological analysis, the lesion was identified as a pleomorphic adenoma without evidence of malignancy (Figure 3). Immunohistochemistry did not show any positive expression of oestrogen or progesterone receptors. Our patient remained well with no evidence of recurrence after a follow-up of one year.
Figure 3

Pleimorphic adenoma without evidence of malignancy (hematoxylin and eosin, original magnification × 100).

Discussion

The incidence of head and neck cancers during pregnancy is rising [3]. Pleomorphic adenomas are characterized by slow growth over a term of several years. Rapid increase or the appearance of facial nerve dysfunction may indicate malignant transformation, which has been reported in 4% of cases. Rapid growth during the third trimester of pregnancy may indicate a possible hormonal influence on pleomorphic adenomas. A scientifically based relationship is not proven [48]. There may be a prognostic association between the expression of progesterone receptors and recurrent pleomorphic adenoma of the parotid gland [9]. Although in this case described here, we could not establish such a relationship, it is possible that unknown factors (e.g. insulin-like growth factor, vascular endothelial growth factor human placental lactogen).are released by the fetoplacental unit, and that these stimulate growth in other end organs such as the parotid

Conclusion

We recommend frequent monitoring of tumors of the salivary glands diagnosed during pregnancy. Indications for early surgical intervention should be discussed on a individual patient basis in a multidisciplinary setting.

Consent

Written informed consent was obtained from the patient for publication of the manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Declarations

Authors’ Affiliations

(1)
Department of Otorhinolaryngology, Head and Neck Surgery Klinikum Bielefeld
(2)
Department of Gynecology and Obstetrics, Klinikum Bielefeld
(3)
Visiting Fellow from Department of Otorhinolaryngology, Head and Neck Surgery Chase Farm & Barnet Hospitals

References

  1. Eveson JW, Cawson RA: Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985, 146: 51-58. 10.1002/path.1711460106.View ArticlePubMedGoogle Scholar
  2. Alphs HH, Eisele DW, Westra WH: The role of fine needle aspiration in the evaluation of parotid masses. Curr Opin Otolaryngol Head Neck Surg. 2006, 14 (2): 62-6. 10.1097/01.moo.0000193184.38310.0a.View ArticlePubMedGoogle Scholar
  3. Atabo A, Bradley PJ: Management principles of head and neck cancers during pregnancy: a review and case series. Oral Oncol. 2008, 44 (3): 236-41. 10.1016/j.oraloncology.2007.02.003.View ArticlePubMedGoogle Scholar
  4. Seifert G: Oralpathologie I. Pathologie der Speicheldrüsen. Springer Verlag Berlin. 1996, Seite 365Google Scholar
  5. Laine M, Ojanotko-Harri A: Progesterone metabolism by major salivary glands of rat. Parotid gland. J Steroid Biochem Mol Biol. 1990, 37 (4): 605-11. 10.1016/0960-0760(90)90408-D.View ArticlePubMedGoogle Scholar
  6. D'Alessandro S, Curbelo HM, Tumilasci OR, Tessler JA: Changes in human parotid salivary protein an sialic acid levels during pregnancy. Arch Oral Biol. 1989, 34 (10): 829-31.View ArticlePubMedGoogle Scholar
  7. Nasser SM, Faquin WC, Dayal Y: Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003, 119 (6): 801-6. 10.1309/RVTP1G0Q727WJUQD.View ArticlePubMedGoogle Scholar
  8. Larbcharoensub N, Cert PK, Tungkeeratichai J, Prakunhungsit S, Narkwong L, Leopairut J: Expression of hormonal receptor in patients with metastasizing pleomorphic adenoma of the major salivary gland; a clinicopathological report of three cases. J Med Assoc Thai. 2009, 92 (9): 1250-5.PubMedGoogle Scholar
  9. Glas AS, Hollema H, Nap RE, Plukker JT: Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland. Cancer. 2002, 94 (8): 2211-6. 10.1002/cncr.10445.View ArticlePubMedGoogle Scholar

Copyright

© Palluch et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement